Le Lézard
Classified in: Health
Subjects: SVY, AVO

Poll: 80% of Virginians only want eye surgeon to perform eye surgery


RICHMOND, Va., Feb. 2, 2022 /PRNewswire-PRWeb/ -- A new poll released today by the Virginia Society of Eye Physicians & Surgeons found an overwhelming majority of Virginians ? 80 percent ? would only trust a trained eye surgeon to perform eye surgery. Just 10 percent said they would allow an optometrist, whose role is to provide primary vision care, to perform surgery on their eyes.

The poll is released as Virginia legislators review two bills in the General Assembly that would allow optometrists to perform laser-eye surgery if certified by the Virginia Board of Optometry. The bills are Senate Bill 375 (J. Chapman Petersen, D-Fairfax City) and House Bill 213 (Roxann L. Robinson, R-Chesterfield).

Laser-eye surgery procedures are common to treat cataracts, glaucoma, and related conditions. They are advanced eye surgeries requiring careful placement of laser energy into the eye. The procedures are never without risk, which is heavily minimized when performed by a medically trained surgeon: an ophthalmologist.

"Eye surgery should be performed by eye surgeons, who have experience and proficiency that only comes with years of education and training supervised by other surgeons, and participating in hundreds of surgeries on real live people," said Michael Keverline, M.D., President of the Virginia Society of Eye Physicians & Surgeons. "Optometrists play a key role in eye and vision care, but it is important to understand where their scope of practice should end, and that is with surgery. Ophthalmologists are the only physicians qualified to perform eye surgery and prepared to manage surgical complications that can and do occur."

The vast majority of states ? 43 ? prohibit laser surgery by optometrists, as does the U.S. Department of Veterans Affairs. Even in those states where laser surgery is allowed for optometrists, few optometrists provide the services and typically not in any rural or underserved areas. Eye surgeons are widely available statewide, even in rural areas. There is no evidence that allowing optometrists to perform laser eye surgery would increase access to care or reduce costs ? reimbursement is the same regardless of specialty. Expanding scope of practice for optometrists may lead to over-utilization of these procedures and drive up costs and health insurance premiums and the need for corrective medical care.

"No need has been demonstrated to change Virginia's standard for eye surgery. Not on access to care, cost, or other patient need," Keverline said. "The only thing we know is that if this legislation passes, inadequately trained practitioners will be performing surgery on people's eyes."

About the Virginia Society of Eye Physicians & Surgeons
As the "Eye MDs" of Virginia, The Virginia Society of Eye Physicians & Surgeons is a statewide, non-profit organization comprised of medical doctors and doctors of osteopathy. The VSEPS mission is to advocate for the best quality eye care through education, legislative efforts and community service. Members are committed to heightening public awareness that eye disease and blindness can be reduced through prevention, and early detection and treatment. Member physicians are dedicated to the public's direct access to ophthalmic care. The organization was chartered in 1920.

About the Poll
The poll was commissioned by the Virginia Society of Eye Physicians and Surgeons and conducted by Mason-Dixon Polling & Strategy from January 13 to 17, 2022 with 625 registered voters statewide. The margin for error is no more than +/- 4 percentage points. For questions on the poll, contact Brad Coker with Mason-Dixon at [email protected] or call (904) 261-2444.

Media Contact

Jeff Kelley, Virginia Society of Eye Physicians & Surgeons, 1 8043979700, [email protected]

 

SOURCE Virginia Society of Eye Physicians & Surgeons


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: